TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).

Kasai H, Allen JT, Mason RM, Kamimura T, Zhang Z. · 2005

Read TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). by Kasai H, Allen JT, Mason RM, Kamimura T, Zhang Z. (2005) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1177991.txt.

Introduction

Kasai, Allen, Mason, Kamimura, and Zhang test whether a growth factor can convert lung lining cells into scar-type cells in this 2005 study. Idiopathic pulmonary fibrosis is a lethal lung scarring disease. Its hallmark, fibroblastic foci, are aggregates of mesenchymal cells under sites of unresolved epithelial injury. Where those cells originate was unclear.

The team treated A549 cells, a human alveolar epithelial cell line, with TGF-beta1, a potent fibrogenic cytokine. Treated cells changed shape and marker profile: they gained mesenchymal markers including a fibronectin form and lost the epithelial marker E-cadherin. Scar-related markers, such as collagens and connective tissue growth factor, were measured by RNA and protein tests. The shift is called epithelial to mesenchymal transition. The authors also investigated which signalling pathway carries the effect.

Catalog record

CREATORKasai H, Allen JT, Mason RM, Kamimura T, Zhang Z.
YEAR2005
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC1177991

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT) By Hidenori Kasai, Jeremy T Allen, Roger M Mason, Takashi Kamimura, Zhi Zhang Published in: Respiratory Research DOI: 10.1186/1465-9921-6-56 ABSTRACT Abstract Background Fibroblastic foci are characteristic features in lung parenchyma of patients with idiopathic pulmonary fibrosis (IPF). They comprise aggregates of mesenchymal cells which underlie sites of unresolved epithelial injury and are associated with progression of fibrosis. However, the cellular origins of these mesenchymal phenotypes remain unclear. We examined whether the potent fibrogenic cytokine TGF-β1 could induce epithelial mesenchymal transition (EMT) in the human alveolar epithelial cell line, A549, and investigated the signaling pathway of TGF-β1-mediated EMT. Methods A549 cells were examined for evidence of EMT after treatment with TGF-β1. EMT was assessed by: morphology under phase-contrast microscopy; Western analysis of cell lysates for expression of mesenchymal phenotypic markers including fibronectin EDA (Fn-EDA), and expression of epithelial phenotypic markers including E-cadherin (E-cad). Markers of fibrogenesis, including collagens and connective tissue growth factor (CTGF) were also evaluated by measuring mRNA level using RT-PCR, and protein by immunofluorescence or Western blotting. Signaling pathways for EMT were characterized by Western analysis of cell lysates using monoclonal antibodies to detect phosphorylated Erk1/2 and Smad2 after TGF-β1 treatment in the presence or absence of MEK inhibitors. The role of Smad2 in TGF-β1-mediated EMT was investigated using siRNA. Results The data showed that TGF-β1, but not TNF-α or IL-1β, induced A549 cells with an alveolar epithelial type II cell phenotype to undergo EMT in a time-and concentration-dependent manner. The process of EMT was accompanied by morphological alteration and expression of the fibroblast phenotypic markers Fn-EDA and vimentin, concomitant with a downregulation of the epithelial phenotype marker E-cad. Furthermore, cells that had undergone EMT showed enhanced expression of markers of fibrogenesis including collagens type I and III and CTGF. MMP-2 expression was also evidenced. TGF-β1-induced EMT occurred through phosphorylation of Smad2 and was inhibited by Smad2 gene silencing; MEK inhibitors failed to attenuate either EMT-associated Smad2 phosphorylation or the observed phenotypic changes. Conclusion Our study shows that TGF-β1 induces A549 alveolar epithelial cells to undergo EMT via Smad2 activation. Our data support the concept of EMT in lung epithelial cells, and suggest the need for further studies to investigate the phenomenon. BACKGROUND Idiopathic pulmonary fibrosis (IPF), the most common pulmonary fibrotic disorder, is a progressive and lethal disease of unknown etiology whose pathogenesis uniquely features the presence of fibroblastic foci in the parenchyma of the lungs [1]. These are comprised of aggregates of mesenchymal cells including fibroblasts and cells which exhibit phenotypic features of myofibroblasts, α-smooth muscle actin (αSMA) expression, increased mitogenic capacity, and enhanced extracellular matrix (ECM) production. The number of fibroblastic foci correlates with worsening lung function, progression of IPF and a poor prognosis [2]. According to the recent epithelial/fibroblastic model of IPF pathogenesis it is considered that fibroblastic foci underlie areas of unresolved epithelial injury and are sites where activated fibroblasts and myofibroblasts migrate, proliferate and synthesize ECM proteins [3]. However, the cellular origins of the mesenchymal phenotypes in fibroblast foci remain unclear. It is now well recognized from many studies that a number of key growth factors are responsible for driving the process of fibrogenesis [4]. For example, transforming growth factor-beta1 (TGF-β1), interleukin-1 beta (IL-1β), and tumor necrosis factor-alpha (TNF-α) are able to induce the characteristic motility, proliferation and ECM synthesis observed in mesenchymal cells with a myofibroblast-like phenotype from fibroblastic foci. In general though, it is levels of TGF-β1 that best correlate with the extent of fibrosis and myofibroblast-like cell induction [5] and TGF-β1 continues to be regarded as the most important of the growth factors involved in pulmonary fibrogenesis [6]. For example, the biologically active form of TGF-β1 was aberrantly expressed in the epithelial cells lining honeycomb cysts within the lung of patients with IPF [7,8]. An increased level of TGF-β1 was found in BAL fluid derived from patients suffering from IPF [8]. Furthermore, overexpression of TGF-β1 in lung tissue induced prolonged pulmonary fibrosis in an animal model [9]. Recent evidence from studies of other fibrotic disorders, including renal [10,11] and liver fibrosis [12], supports a view that TGF-β1 may play a novel role in pulmonary fibrogenesis by promoting alveolar epithelial cell transition to form mesenchymal cells with a myofibroblast-like phenotype [10-14]. This process, termed epithelial-mesenchymal transition (EMT), occurs widely under both physiologic and pathologic conditions, for example during normal wound healing [13] and renal fibrosis [10,11]. Very recently it was reported that TGF-β1 induced type II alveolar epithelial cells isolated from rat lung to undergo EMT [15]. Epithelial cells are polarised, and display cytokeratin filaments and membrane-associated junctions. During EMT membrane-associated adherens junctions and desmosomes are dissociated, whilst at the same time or shortly after, cytoskeletal rearrangement takes place and mRNA for intermediate filament proteins is increased, facilitating the cell adopting a mesenchymal phenotype [14]. E-cadherin (E-cad) is an epithelial cell transmembrane protein whose extracellular domain interacts with that of an E-cad molecule expressed by an adjacent cell. It has a critical role in establishing firm adhesion, maintaining cell polarity and epithelial tightness [16]. The cadherin complex suppresses the dissociation of epithelial cells, and thus, the crucial step of EMT is the downregulation of E-cad [14]. To begin to understand the role of EMT in the development of fibroblastic foci in IPF, we have examined whether TGF-β1 can induce EMT in a human lung epithelial cell line (A549). A549 cells retain important characteristics of alveolar type II epithelial cells and have been employed in numerous studies as a valuable tool for studying promoter activity [17], apoptosis [18], and alveolar epithelial cell DNA damage [19]. In this study we demonstrate that TGF-β1 induces EMT in human type II alveolar epithelial cells through the activation of Smad2, and that this transition is accompanied by functional changes that are relevant to the progression of lung fibrosis. METHODS Materials Recombinant human TGF-β1, human IL-1β; and TNF-α were purchased from R&D systems (Minneapolis, MN). A mouse monoclonal antibody against human E-cad was from BD Transduction Laboratory (Oxford, UK). Mouse monoclonal anti-human fibronectin EDA+ splice form (Fn-EDA) and anti-human cytokeratin-19 were purchased from Abcam Ltd (Cambridge, UK). Goat anti-actin (C-11), Smad2 (S-20) and connective tissue growth factor (CTGF) polyclonal antibodies were supplied by Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit anti-Erk1/2 and rabbit anti-phosphorylated Erk1/2 polyclonal antibodies were purchased from New England Biolabs (Hertfordshire, UK). Both biotinylated and non-biotinylated goat anti-human collagen type I, type III, and type IV polyclonal antibodies, and their standard proteins were supplied by Chemicon International (Temecula, CA). Rabbit anti-mouse immunoglobulin-HRP, rabbit anti-goat immunoglobulin-HRP and goat anti-rabbit immunoglobulin HRP were from DAKO Ltd (Cambridgeshire, UK). Rabbit anti-goat IgG-fluorescein (FITC) was purchased from Vector Labs (Perterborough, UK). Alkaline phosphatase-conjugated anti-Extravidin was supplied by Sigma (Dorset, Poole). PD-098059 and U-0126 were supplied by Merck Bioscience Ltd (Nottingham, UK). SMARTpool SMAD2 and non-specific control pool were purchased from Dharmacon, Inc. (Chicago, IL). Cell culture Human type II alveolar epithelial cells (A549) were supplied from ATCC/LGC Promochem (Middlesex, UK). Cells were maintained in low glucose-DMEM containing 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin and 100 ug/ml streptomycin at 37°C in a humidified 5% CO2 atmosphere. Confluent cultures of cells were maintained in serum-free DMEM containing

Read the complete text